Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

SG&A

Share-based compensation expense

Asset impairment and restructuring costs

Expected credit losses on financial assets and related charges

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Canopy Growth

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Earnings data Q3 2025

Revenue

Cost of revenue

Gross profit

Operating expenses

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Canopy Growth Corp. engages in the production, distribution, and sale of cannabis and cannabinoid-based products for both adult-use and medical purposes. The firm operates through the following segments: Canada Cannabis, Rest-of-world Cannabis, Storz and Bickel, BioSteel, This Works, and Other. The Canada Cannabis segment includes the production, distribution, and sale of cannabis, hemp, and cannabis products in Canada. The Rest-of-world Cannabis segment focuses on production and sale of cannabis, hemp, and cannabis products internationally. The Storz and Bickel segment produces and sells vaporizers. The BioSteel segment refers to the sale of consumer packaged goods including sports nutrition beverages, hydration mixes, proteins, and other specialty nutrition products. The This Works segment includes the production and sale of beauty, skincare, wellness, and sleep products, some of which have been blended with hemp-derived CBD isolate. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.

Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.33. This compares to loss of $2.30 per share a year ago.

Canopy Growth Corporation (CGC) Reports Q4 Loss, Tops Revenue Estimates

Canopy Growth Corp.'s stock CGC, was up fractionally in premarket trading on Thursday after the Canadian cannabis company reported a lower loss on higher revenue and lower expenses. Canopy Growth's fourth-quarter loss narrowed to C$92.3 million, or C$1.03 a share, from C$640.1 million, or C$12.83 a share, in the year-ago quarter.

Canopy Growth loss narrows as operating expenses drop

Storz & Bickel® delivered its best Q4 revenue quarter, with net revenue increasing 43% as compared to Q4 2023 Canada medical cannabis net revenue increased 16% in Q4 FY2024 and 10% in FY2024 year-over-year            Canada cannabis Cost of Goods Sold decreased by 54% in FY2024 versus FY2023 Following recent balance sheet actions, the Company has no material debt obligation due until March 2026 1 SMITHS FALLS, ON , May 30, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy", "Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis, today announced its financial results for the fourth quarter and fiscal year ended March 31, 2024 and the filing of an annual report on Form 10-K, including the audited consolidated financial statements for the fiscal year ended March 31, 2024 and the unqualified report thereon of the Company's independent registered public accounting firm.  All financial information in this press release is reported in Canadian dollars, unless otherwise indicated.

Canopy Growth Reports Fourth Quarter and Fiscal Year 2024 Financial Results; Q4 FY2024 Net Revenue increased 7% year-over-year, or 16% excluding divested businesses

Canopy Growth's (CGC) rightsized cannabis-focused business is a major foundation for growth.

Should You Buy Canopy Growth (CGC) Ahead of Q4 Earnings?

Aurora Cannabis

SNDL Inc.

Recently, the cannabis market received the best hoped-for news. The Drug Enforcement Administration (DEA) announced it is moving forward with plans to reschedule marijuana from a Schedule I to a Schedule III controlled substance.

3 Sorry Cannabis Stocks to Sell in May While You Still Can

In the closing of the recent trading day, Canopy Growth Corporation (CGC) stood at $9.18, denoting a +0.77% change from the preceding trading day.

Canopy Growth Corporation (CGC) Rises Higher Than Market: Key Facts

Canopy Growth (CGC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Canopy Growth Corporation (CGC) Report Negative Earnings Next Week? What You Should Know

Agenus

Curaleaf Holdings, Inc.

Small- and mid-cap stocks are known to be highly sensitive to interest rates. With the Federal Reserve expected to start cutting rates no later than 2025, these equities may be on the verge of a turnaround.

3 Magnificent Growth Stocks to Buy Hand Over Fist

OrganiGram Holdings Inc.

As Memorial Day weekend approaches, investors are eyeing top Canadian marijuana stocks. These stocks have shown potential for significant growth. The global cannabis industry is expected to be worth over $73 billion by 2027, according to Grand View Research. Canada's leading cannabis companies, such as Canopy Growth and Aurora Cannabis, continue to dominate the market. They offer strong investment opportunities. Recently, news about U.S. legalization efforts has stirred the market. The SAFE Banking Act is gaining momentum in Congress, which could boost Canadian stocks with U.S. ties. This legislation aims to provide financial services to cannabis businesses.

Best Canadian Cannabis Stocks to Watch Right Now

Franklin Resources

Hormel Foods

Going against the crowd isn't easy. When everyone runs one way, it is hard to charge ahead in the other direction.

Contrarian Bets: 3 Stocks Wall Street Hates That You Should Love

Canopy Growth Corporation (CGC) concluded the recent trading session at $10.85, signifying a -1.36% move from its prior day's close.

Canopy Growth Corporation (CGC) Stock Sinks As Market Gains: Here's Why

On paper, stakeholders of cannabis operator Canopy Growth (NASDAQ: CGC ) have plenty of reasons to smile. Anticipation of major marijuana policy shifts culminated in a recent announcement by President Joe Biden that the government will reclassify the controversial plant.

Should You Buy Canopy Growth (CGC) Stock Before May 30?

Fans of Canopy Growth (NASDAQ: CGC ) stock have plenty to look forward to following a recent proposal to reschedule cannabis. This, of course, includes its upcoming first-quarter earnings report, due on May 30.

Dear CGC Stock Fans, Mark Your Calendars for May 30

Canopy Growth (CGC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Strength Seen in Canopy Growth (CGC): Can Its 11.0% Jump Turn into More Strength?

Cronos Group

AdvisorShares Pure US Cannabis ETF

Tilray Brands

Cannabis stocks are once again on the move today, with some big names being seen across the sector. Shares of Canopy Growth (NASDAQ: CGC ), Tilray (NASDAQ: TLRY ), Aurora Cannabis (NASDAQ: ACB ), AdvisorShares Pure US Cannabis ETF (NYSEARCA: MSOS ), and Cronos (NASDAQ: CRON ) are all up between 2% and 10% in today's session, with Canopy Growth leading the way higher.

Cannabis Stocks CGC, TLRY, ACB, MSOS, CRON Pop as Justice Department Moves on Rescheduling

Green Thumb Industries Inc.

Innovative Industrial Properties

NewLake Capital Partners, Inc.

Trulieve Cannabis Corp.

Alex Carchidi is bullish on the cannabis sector but not ready to invest in stocks, except for Innovative Industrial Properties. 2 cannabis stocks worth considering are Green Thumb Industries and Trulieve Cannabis.

Looking For The Bud Light Of Cannabis

SMITHS FALLS, ON , May 16, 2024 /PRNewswire/ - Canopy Growth Corporation ("Canopy Growth" or the "Company") (TSX: WEED) (NASDAQ: CGC), a world-leading cannabis company dedicated to unleashing the power of cannabis, will release its financial results for the fourth quarter and fiscal year 2024 ended March 31, 2024 before financial markets open on May 30, 2024. Following the release of its fourth quarter and fiscal year 2024 financial results, Canopy Growth will host an audio webcast with David Klein, CEO and Judy Hong, CFO on May 30, at 10 AM Eastern Time.

Canopy Growth to Report Fourth Quarter and Fiscal Year 2024 Financial Results on May 30, 2024

Mullen Automotive

New Gold

There are several cheap  penny stocks that investors can consider, even as major market indices like the S&P 500 and Nasdaq continue to rise. The performance of these stocks can be influenced by the overall economic environment, potentially leading to significant returns for investors.

7 Cheap Penny Stocks to Buy Now: May 2024

Mastercard

PayPal

Visa

When Ellis Soodak was planning the launch of Verdi Cannabis dispensary in New York City, he didn't want to face the dangers his father did at the family's liquor store in the 1970s and 80s.

Card payments remain a ‘challenge' for legal cannabis as major banks avoid the sector. Changing classification won't help.

Village Farms International

As we explore the bustling Canadian cannabis market, several marijuana stocks stand out this week, warranting a closer look. These companies, thriving amid a globally expanding industry, have shown resilience and innovation. Recent statistics reveal the global cannabis market could reach USD 197.74 billion by 2028, according to Grand View Research. This forecast underscores significant growth potential, driven by increasing legalization and medical usage.

May 2024 Watchlist: Top Canadian Cannabis Stocks Heating Up the Market

Greenlane Holdings

As the cannabis industry continues its growth in 2024, a confluence of regulatory, demographic, and market trends is shaping the sector. This has presented a fertile ground for savvy investors. Here's a deeper look into the evolving landscape of cannabis investments. This year could mark a significant turning point with the potential rescheduling of cannabis at the federal level. If cannabis can one day be federally legal it would be the biggest win for the industry.

This Is How Marijuana Stocks Will Be Impacted By Reform In 2024

What will happen to marijuana stocks if cannabis does not get rescheduled? Some see this as a possibility and investors want to be prepared. With all the recent talks of cannabis being dropped from a scheduled 1 to a class 3 substance it has led to a rise in trading. The speculation of what's next to come is also feeding into momentum pouring into the sector.

Ready To Invest? Here Are 3 Top Marijuana Stocks For You

Cannabis stocks are back in the spotlight and moving higher on news that the U.S. government is moving to reclassify the recreational drug and ease federal restrictions imposed on it. The Biden administration has taken steps to reclassify cannabis, also known as marijuana, as a Schedule III substance.

The 3 Best Cannabis Stocks to Buy in May 2024

Jazz Pharmaceuticals

Leafly Holdings

Among the emerging industries that have captured the attention of investors is the cannabis sector. The cannabis industry has experienced remarkable growth, giving rise to a new breed of top cannabis stocks to buy for investments in May.

7 Cannabis Stocks to Buy for a Smoking-Hot 2024

Canopy Growth Corporation (TSX:WEED, NYSE:CGC) has confirmed it has exercised its options to acquire American cannabis assets Wana Brands and Jetty Extracts, kicking off its expansion into the US market. This comes after Canopy Growth shareholders in mid-April approved a new exchangeable share structure that will allow it to operate in the US under a US-domiciled holding company called Canopy USA.

Canopy Growth begins expansion into US with Wana Brands and Jetty Extracts acquisitions

News for Canopy Growth Stock (CGC)